Su En Kui - Net Worth and Insider Trading
Su En Kui Net Worth
The estimated net worth of Su En Kui is at least $36 Million dollars as of 2024-09-27. Su En Kui is the Director of Getein Biotech Inc and owns about 4,298,283 shares of Getein Biotech Inc (SHSE:603387) stock worth over $36 Million. Details can be seen in Su En Kui's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Su En Kui has not made any transactions after 2022-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Su En Kui
Su En Kui Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Su En Kui owns 1 companies in total, including Getein Biotech Inc (SHSE:603387) .
Click here to see the complete history of Su En Kui’s form 4 insider trades.
Insider Ownership Summary of Su En Kui
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:603387 | Getein Biotech Inc | 2022-11-18 | Director |
Su En Kui Latest Holdings Summary
Su En Kui currently owns a total of 1 stock. Su En Kui owns 4,298,283 shares of Getein Biotech Inc (SHSE:603387) as of November 18, 2022, with a value of $36 Million.
Latest Holdings of Su En Kui
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:603387 | Getein Biotech Inc | 2022-11-18 | 4,298,283 | 8.28 | 35,589,783 |
Holding Weightings of Su En Kui
Su En Kui Form 4 Trading Tracker
According to the SEC Form 4 filings, Su En Kui has made a total of 10 transactions in Getein Biotech Inc (SHSE:603387) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Getein Biotech Inc is the sale of 70,000 shares on November 18, 2022, which brought Su En Kui around $972,230.
Insider Trading History of Su En Kui
- 1
Su En Kui Trading Performance
GuruFocus tracks the stock performance after each of Su En Kui's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Su En Kui is -12.76%. GuruFocus also compares Su En Kui's trading performance to market benchmark return within the same time period. The performance of stocks bought by Su En Kui within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Su En Kui's insider trading performs compared to the benchmark.
Performance of Su En Kui
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.1 | | | | | |
| Relative Return to S&P 500(%) | -7.31 | | | | | |
Su En Kui Ownership Network
Ownership Network List of Su En Kui
Ownership Network Relation of Su En Kui
Su En Kui Owned Company Details
What does Getein Biotech Inc do?
Who are the key executives at Getein Biotech Inc?
Su En Kui is the Director of Getein Biotech Inc.
Getein Biotech Inc (SHSE:603387) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Getein Biotech Inc (SHSE:603387) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Getein Biotech Inc (SHSE:603387) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Getein Biotech Inc (SHSE:603387)'s detailed insider trading history can be found in Insider Trading Tracker table.
Getein Biotech Inc Insider Transactions
Su En Kui Mailing Address
Above is the net worth, insider trading, and ownership report for Su En Kui. Currently GuruFocus does not have mailing address information for Su En Kui.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
